相关实验视频

Updated: Jul 1, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.2K

彻底改变抗击局部晚期乳腺癌的战斗:对新辅助放射治疗的全面洞察

Xiangyi Kong1,2, Jiarui Song2, Peng Gao1,3

  • 1Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Medicinal research reviews
|November 10, 2023
PubMed
概括

局部晚期乳腺癌 (LABC) 是一个重大挑战. 手术前的新辅助放射治疗 (NART) 在减少瘤体积和转移方面显示出有前途,改善了患者的治疗结果.

关键词:
在本地发达的乳腺癌.进行乳房切除术,即乳房切除术.新辅助性放射疗法新辅助性放射疗法审查 审查 审查 审查 审查 审查

更多相关视频

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.8K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...